Neogen Corp. has appointed Jennifer Evans Stacey as chief legal and compliance officer and board secretary.
Stacey is an accomplished chief legal and compliance officer and board secretary with extensive experience in the life sciences industry. She has served more than 10 years as a public company chief legal and compliance officer and board secretary, as well as five years as a public company board member. Over her more than 25-year career, she has led legal, compliance, government relations, corporate communications and human resources functions, operating in complex, fast-moving environments.
Most recently, Stacey served as chief legal and compliance officer and secretary at Galera Therapeutics Inc., a publicly traded biopharmaceutical company focused on oncology. Prior to Galera, she held chief legal officer roles at The Wistar Institute, Antares Pharma Inc., FXI Inc., Auxilium Pharmaceuticals Inc., and Aventis Behring LLC. Stacey serves on the board of directors of Context Therapeutics, a publicly traded, clinical stage biopharmaceutical company advancing T cell-engaging bispecific antibodies for solid tumors.
“Jennifer’s experience and life sciences background position her well to support Neogen’s focus on organic growth through innovation and technology licensing, as well as future inorganic growth opportunities,” said Mike Nassif, president and CEO of Neogen. “We’re pleased to welcome her to the leadership team and look forward to her contributions.”
Stacey holds a Bachelor of Arts degree, magna cum laude, from Princeton University and a Juris Doctor from the University of Pennsylvania Law School.
“Neogen plays an important role in helping to protect the global food supply, and that responsibility requires strong governance and a clear focus on execution,” Stacey said. “I’m looking forward to partnering with the leadership team to support the business, enhance our compliance framework, and help position the company for sustainable, long-term growth.”
